MATTHEW ASMAR: Open Payments
NPI 1225573512 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,858 in 226 payments from 24 companies in 2025. Trend: 2023 $3,631 · 2024 $3,996 · 2025 $4,858
Food & beverage: $4,612Education: $246
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $878 |
| Novartis Pharmaceuticals Corporation | 17 | $476 |
| GENZYME CORPORATION | 11 | $418 |
| Arcutis Biotherapeutics, Inc. | 21 | $374 |
| Janssen Biotech, Inc. | 14 | $345 |
| Regeneron Healthcare Solutions, Inc. | 13 | $318 |
| PFIZER INC. | 17 | $284 |
| UCB, Inc. | 9 | $250 |
| Galderma Laboratories, L.P. | 17 | $226 |
| Botanix SB Inc | 14 | $192 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, Zoryve, TREMFYA, COSENTYX, Bimzelx, CIBINQO.
Industry payments across NJ — which companies pay providers there.
